RBMS3 and cancer: The analysis of the immunohistochemical expression of RBMS3 in 490 cases of IDC and 26 cases of mastopathy showed a statistically significant decrease in RBMS3 expression in the cancer specimens compared to the mastopathy samples (Mann–Whitney test p < 0.001, Figure 1a, Figure 2a,b).